Grand River Aseptic Manufacturing (GRAM) is a private contract development and manufacturing organization (CDMO) based in Grand Rapids, Michigan, specializing in sterile injectable fill–finish services for vials, syringes, and cartridges. Founded in 2010 by the Van Andel Institute and Grand Valley State University, GRAM has grown significantly under Arlington Capital Partners’ ownership since 2017, expanding to over 450,000 square feet across five facilities. The company provides clinical and commercial-scale manufacturing, terminal sterilization, and analytical testing, and has supported U.S. government vaccine initiatives for COVID-19 and monkeypox. GRAM has been recognized multiple times on the Inc. 5000 list and for its workplace excellence.
History
GRAM was founded in 2010 by Van Andel Institute and Grand Valley State University.[1]
In 2017, Arlington Capital Partners, a private equity firm in Washington, D.C. took a majority ownership stake in GRAM.[3]
In June 2020, GRAM finished a $60 million expansion to install a 61,500-square-foot fill-finish injectable facility on the same site to triple GRAM's manufacturing footprint to more than 100,000 square feet of production space.
In 2020, BARDA